Gland Pharma Limited has informed the Exchange about Schedule of meet
GLAND · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Gland Pharma has informed the stock exchanges about a scheduled one-on-one meeting with White Oak Capital Management on June 05, 2025. This disclosure is filed under SEBI's Listing Obligations and Disclosure Requirements (Regulation 30). The company has noted that the schedule is subject to change due to last-minute exigencies. The intimation was signed by Sampath Kumar Pallerlamudi, Company Secretary & Compliance Officer.
This is a routine regulatory disclosure of a planned investor engagement and does not by itself carry material information for shareholders. However, one-on-one meetings with asset managers like White Oak Capital may reflect ongoing institutional interest, which is mildly positive for investor sentiment.